One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.4037.4037
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
Affiliation: Dana-Farber Cancer Institute, University of Nebraska Medical Center, University of Rochester, Emory University, University of Pennsylvania, Swedish Medical Center, Rocky Mountain Cancer Centers, Columbia University Irving Medical Center, CDG Therapeutics (United States), Georgetown University Medical Center, Duke Medical Center, Queen Mary University of London, City Of Hope National Medical Center, The University of Texas MD Anderson Cancer Center, University of Bologna, Moffitt Cancer Center, Levine Cancer Institute, Rush University Medical Center, Sarah Cannon, Clearview Cancer Institute, Dartmouth–Hitchcock Medical Center, Oregon Health & Science University, University of California, IrvineAn Integrated Safety Analysis of the Next Generation PI3Kδ Inhibitor Umbralisib (TGR-1202) in Patients with Relapsed/Refractory Lymphoid Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
